These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24119913)

  • 41. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
    Sarkar I; Garg R; van Drunen Littel-van den Hurk S
    Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.
    Scagnolari C; Midulla F; Pierangeli A; Moretti C; Bonci E; Berardi R; De Angelis D; Selvaggi C; Di Marco P; Girardi E; Antonelli G
    Clin Vaccine Immunol; 2009 Jun; 16(6):816-23. PubMed ID: 19386802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
    Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunology of bovine respiratory syncytial virus in calves.
    Guzman E; Taylor G
    Mol Immunol; 2015 Jul; 66(1):48-56. PubMed ID: 25553595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure.
    Grad YH; Newman R; Zody M; Yang X; Murphy R; Qu J; Malboeuf CM; Levin JZ; Lipsitch M; DeVincenzo J
    J Virol; 2014 Jul; 88(13):7286-93. PubMed ID: 24741088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis.
    Sebina I; Phipps S
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32726921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection.
    Jung HE; Kim TH; Lee HK
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The innate immune response to RSV: Advances in our understanding of critical viral and host factors.
    Sun Y; López CB
    Vaccine; 2017 Jan; 35(3):481-488. PubMed ID: 27686836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
    Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human genetics and respiratory syncytial virus disease: current findings and future approaches.
    Choi EH; Lee HJ; Chanock SJ
    Curr Top Microbiol Immunol; 2013; 372():121-37. PubMed ID: 24362687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
    Piedra FA; Mei M; Avadhanula V; Mehta R; Aideyan L; Garofalo RP; Piedra PA
    PLoS One; 2017; 12(3):e0172953. PubMed ID: 28267794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in and the potential of vaccines for respiratory syncytial virus.
    Jorquera PA; Oakley KE; Tripp RA
    Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages.
    Pokharel SM; Shil NK; Bose S
    Front Cell Infect Microbiol; 2016; 6():174. PubMed ID: 28018859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus.
    Levitz R; Gao Y; Dozmorov I; Song R; Wakeland EK; Kahn JS
    PLoS One; 2017; 12(9):e0184318. PubMed ID: 28877226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.
    Olivier AK; Gallup JM; van Geelen A; Ackermann MR
    Exp Lung Res; 2011 Apr; 37(3):131-43. PubMed ID: 21309731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.
    Rosenberg HF; Domachowske JB
    Curr Med Chem; 2012; 19(10):1424-31. PubMed ID: 22360479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
    Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
    Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
    Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
    Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.